# Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide

> **NCT01366365** · PHASE1 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 28 (actual)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** methylnaltrexone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01366365
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01366365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01366365, "Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01366365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*